Study of ADSTEM Injection for Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis

NCT07377838 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

286

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

BIOLOGICAL: ADSTEM Inj.
DRUG: Placebo

Sponsor

EHL Bio Co., Ltd.